Kamada Ltd.
Kamada Ltd. (KMDA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kmda · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Kamada Ltd. (KMDA) measures how much investors pay for each dollar of the company's trailing earnings. KMDA's current PE ratio of 20.98x is calculated by dividing its stock price of $7.24 by its TTM earnings per share of $0.35. −4.2% discount vs 5Y avg 21.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 9 fiscal years · Front-end computedMinQ1 · 25%24.2x
MedianQ3 · 75%1138.3x
Max
At 20.98x, KMDA's current P/E is within its average historical range over the past 9 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kamada Ltd.You KMDA | $418M | 20.98x | — | $0.35 |
 Auna S.A. AUNA | $335M | 5.10x | — | $3.24 |
 Evolus, Inc. EOLS | $440M | N/A | — | -$0.80 |
 Galectin Therapeutics Inc. GALT | $158M | N/A | — | -$0.48 |
 PureTech Health plc PRTC | $410M | N/A | — | -$45.58 |
 Quantum-Si incorporated QSI | $210M | N/A | — | -$0.51 |
 Rocket Pharmaceuticals, Inc. RCKT | $295M | N/A | — | -$2.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 20.15x | $0.35 | -16.8% | |
2024-12-31 FY2024 | 24.21x | $0.25 | -32.9% | |
2023-12-31 FY2023 | 36.07x | $0.17 | — | |
2022-12-31 FY2022 | — | $-0.05 | — | |
2021-12-31 FY2021 | — | $-0.05 | — | |
2020-12-31 FY2020 | 16.69x | $0.39 | +34.8% | |
2019-12-31 FY2019 | 12.38x | $0.55 | +37.0% | |
2018-12-31 FY2018 | 9.03x | $0.55 | -65.8% | |
2017-12-31 FY2017 | 26.41x | $0.18 | — | |
2016-12-31 FY2016 | — | $-0.18 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kamada Ltd. (KMDA) measures how much investors pay for each dollar of the company's trailing earnings. KMDA's current PE ratio of 20.98x is calculated by dividing its stock price of $7.24 by its TTM earnings per share of $0.35.
Frequently asked questions
KMDA pe ratio · 6 questionsKMDA's current PE ratio is 20.98x as of 2026-06-08, based on a stock price of $7.24 and TTM EPS of $0.35. Data sourced from Financial Modeling Prep via KMDA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kamada Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08